Elite Pharmaceuticals, Inc. (ELTP)
Market Cap | 384.69M |
Revenue (ttm) | 66.45M |
Net Income (ttm) | 19.58M |
Shares Out | 1.07B |
EPS (ttm) | 0.02 |
PE Ratio | 18.92 |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 1,842,045 |
Open | 0.369 |
Previous Close | 0.360 |
Day's Range | 0.369 - 0.392 |
52-Week Range | 0.080 - 0.420 |
Beta | 0.16 |
Analysts | n/a |
Price Target | n/a |
Earnings Date | Nov 14, 2024 |
About Elite Pharmaceuticals
Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. The company operates through Abbreviated New Drug Applications for Generic Pharmaceuticals and New Drug Applications for Branded Pharmaceuticals segments. It owns, licenses, manufactures, and sells various generic and oral dose pharmaceuticals products, such as Phentermine HCl 37.5mg tablets, and 15mg and 30mg capsules for the treatment of bariatrics under Adipex-P ... [Read more]
Full Company ProfileFinancial Performance
In 2023, Elite Pharmaceuticals's revenue was $56.63 million, an increase of 65.79% compared to the previous year's $34.16 million. Earnings were $20.11 million, an increase of 464.56%.
Financial StatementsNews
Elite Pharmaceuticals Announces Commercial Launch of Generic Methotrexate Sodium
Northvale, New Jersey--(Newsfile Corp. - August 27, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products, ...
Elite Pharmaceuticals, Inc. (ELTP) Q1 2025 Earnings Call Transcript
Elite Pharmaceuticals, Inc. (OTCQB:ELTP) Q1 2025 Earnings Conference Call August 15, 2024 11:30 AM ET Company Participants Nasrat Hakim – President and Chief Executive Officer Carter Ward – Chief Fina...
Elite Pharmaceuticals reports Q1 results
Elite Pharmaceuticals press release (ELTP): Q1 Revenue of $18.8M, an increase of $9.8 million or approximately 109% as compared to the comparable period of the prior fiscal year.
Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2025 Ended June 30, 2024 and Provides Conference Call Information
Conference Call Scheduled for Thursday, August 15 at 11:30 AM EDT Northvale, New Jersey--(Newsfile Corp. - August 14, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a sp...
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2025 Financial Results on August 15, 2024
Financials for First Quarter of Fiscal Year 2025 Ended June 30, 2024 will be released on August 14, 2024 Northvale, New Jersey--(Newsfile Corp. - August 9, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ...
Elite Pharmaceuticals, Inc. (ELTP) Q4 2024 Earnings Call Transcript
Elite Pharmaceuticals, Inc. (OTCQB:ELTP) Q4 2024 Earnings Conference Call July 2, 2024 11:30 AM ET Company Participants Nasrat Hakim - President and CEO Carter Ward - CFO, Secretary and Treasurer Conf...
Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Conference Call Information
Conference Call Scheduled for Tuesday, July 2 at 11:30 AM EDT Northvale, New Jersey--(Newsfile Corp. - July 1, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty...
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2024 Financial Results on July 2, 2024
Financials for Fiscal Year 2024 Ended March 31, 2024 will be released on July 1, 2024 Northvale, New Jersey--(Newsfile Corp. - June 26, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or th...
Elite Pharmaceuticals Receives FDA Approval for Generic Methotrexate
NORTHVALE, NJ / ACCESSWIRE / May 20, 2024 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, today announced t...
Elite Pharmaceuticals, Inc. (ELTP) Q3 2024 Earnings Call Transcript
Elite Pharmaceuticals, Inc. (ELTP) Q3 2024 Earnings Call Transcript
Elite Pharmaceuticals, Inc. Reports Financial Results for Third Quarter of Fiscal Year 2024 ended December 31, 2023 and Provides Conference Call Information
Conference Call Scheduled for Thursday, February 15 at 11:30 AM EST NORTHVALE, NJ / ACCESSWIRE / February 14, 2024 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company")(OTCBB:ELTP), a specialty pha...
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2024 Financial Results on February 15, 2024
Financials for Third Quarter Fiscal Year 2024 Ended December 31, 2023 will be released on February 14, 2024 NORTHVALE, NJ / ACCESSWIRE / February 8, 2024 / Elite Pharmaceuticals, Inc. ("Elite" or the ...
Elite Pharmaceuticals Files ANDA with US FDA to Market Central Nervous System Stimulant
NORTHVALE, NJ / ACCESSWIRE / December 26, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP), a specialty pharmaceutical company engaged in the development, manufacture, and di...
Elite Pharmaceuticals Announces First Product Shipment of Generic Adderall XR(R) to Marketing Partner Prasco, LLC
NORTHVALE, NJ / ACCESSWIRE / December 12, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, today announ...
Elite Pharmaceuticals, Inc. (ELTP) Q2 2024 Earnings Call Transcript
Elite Pharmaceuticals, Inc. (OTCQB:ELTP) Q2 2024 Earnings Call Transcript November 15, 2023 11:30 AM ET Company Participants Nasrat Hakim - President and Chief Executive Officer Carter Ward - Chief Fi...
Elite Pharmaceuticals, Inc. Reports Financial Results for Second Quarter of Fiscal Year 2024 ended September 30, 2023 and Provides Conference Call Information
Conference Call Scheduled for Wednesday, November 15 at 11:30 AM EST NORTHVALE, NJ / ACCESSWIRE / November 14, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty p...
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2024 Financial Results on November 15, 2023
Financials for Second Quarter Fiscal Year 2024 Ended September 30, 2023 will be released on November 14, 2023 NORTHVALE, NJ / ACCESSWIRE / November 10, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or t...
Elite Pharmaceuticals Files ANDA with US FDA to Market Opiate Analgesic Product
NORTHVALE, NJ / ACCESSWIRE / September 25, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company")(OTCQB:ELTP), a specialty pharmaceutical company engaged in the development, manufacture, and di...
Elite Pharmaceuticals, Inc. Appoints Carter Ward as Chief Financial Officer
NORTHVALE, NJ / ACCESSWIRE / September 7, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing and manufacturing niche generic prod...
Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study
NORTHVALE, NJ / ACCESSWIRE / August 28, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company")(OTCQB:ELTP), a specialty pharmaceutical company engaged in the development, manufacture, and distr...
Elite Pharmaceuticals, Inc. (ELTP) Q1 2024 Earnings Call Transcript
Elite Pharmaceuticals, Inc. (OTCQB:ELTP) Q1 2024 Results Conference Call August 15, 2023 11:30 AM ET Company Participants Nasrat Hakim - President and Chief Executive Officer Operator Good morning, la...
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2024 Financial Results on August 15, 2023
Financials for First Quarter Fiscal Year 2024 Ended June 30, 2023 will be released on August 14, 2023 NORTHVALE, NJ / ACCESSWIRE / August 9, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company...
Elite Pharmaceuticals, Inc. (ELTP) Q4 2023 Earnings Call Transcript
Elite Pharmaceuticals, Inc. (OTCQB:ELTP) Q4 2023 Earnings Conference Call June 30, 2023 11:30 AM ET Company Participants Nasrat Hakim - President and Chief Executive Officer Conference Call Participan...
Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2023 and Provides Conference Call Information
Conference Call Scheduled for Friday, June 30 at 11:30 AM EDT NORTHVALE, NJ / ACCESSWIRE / June 29, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutic...
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2023 Financial Results on June 30, 2023
Financials for Fiscal Year 2023 Ended March 31, 2023 will be released on June 29, 2023 NORTHVALE, NJ / ACCESSWIRE / June 22, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP),...